Anteis

Meyrin, Switzerland Founded: 2003 • Age: 23 yrs Acquired By Merz
Biopolymer-based injectable medical devices are developed for aesthetics and surgery.

About Anteis

Anteis is a Healthcare company based in Meyrin (Switzerland) founded in 2003, and was acquired by Merz in November 2013. Biopolymer-based injectable medical devices are developed for aesthetics and surgery. Its focus areas include Diversified Medical Devices.

Company details

Anteis develops biopolymer injectables and injection technologies based on biopolymer transformation. The companys products consist mainly of medical devices for Aesthetic medicine such as wrinkle fillers, body contouring, skin rehydration products; Surgical ophthalmology i.e. products for cataract and glaucoma surgery; and Orthopedics Rheumatology, for example, viscoantalgics for osteoarthritis. Anteis has 2 factories located in Switzerland, and distributes its products through an international distributors network among more than 90 countries including Europe, Brazil, Japan and USA. Anteis was acquired by Merz Pharma in 2013 from previous owners, the private equity investor Signet Healthcare Partners.

  • Headquarters Meyrin, Switzerland
  • Stage Acquired
  • Sectors
    Healthcare
  • Website anteis.com
  • Social LinkedIn X
  • Acquired by Merz (Nov 2013)
Key Metrics

Investors in Anteis

Anteis has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Merz.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Merz is recognized as a leader in aesthetic medicine and neurotoxin therapy.
1918merz.comFrankfurt am Main, Germany
Premium access

Investor details for Anteis

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Anteis

2 dated milestones of Anteis across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Anteis is founded.
  2. Exit Acquired by Merz.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Anteis

Anteis was founded in 2003.

Anteis is headquartered in Meyrin, Switzerland. It is registered at Meyrin, Geneva, Switzerland.

Anteis develops biopolymer injectables and injection technologies based on biopolymer transformation. The companys products consist mainly of medical devices for Aesthetic medicine such as wrinkle fillers, body contouring, skin rehydration products; Surgical ophthalmology i.e. products for cataract and glaucoma surgery; and Orthopedics Rheumatology, for example, viscoantalgics for osteoarthritis. Anteis has 2 factories located in Switzerland, and distributes its products through an international distributors network among more than 90 countries including Europe, Brazil, Japan and USA. Anteis was acquired by Merz Pharma in 2013 from previous owners, the private equity investor Signet Healthcare Partners.

Anteis has 1 investor. Key investors include Merz.

Yes. Anteis was acquired by Merz in November 2013.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available